Roche Prepares to Make Devices for Drug Using Halozyme Technology

San Diego-based Halozyme Therapeutics … partner Roche announced plans to invest $182 million in two European factories that will produce a device designed to deliver a drug formulated with Halozyme’s enzyme technology.
Xconomy